# FDA Inspection 1118290 - Robert Litman, M.D. - February 20, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/robert-litman-md/1e74bc9b-1ed3-4969-9cfd-35fc95e70562
Source feed: FDA_Inspections

> FDA Inspection 1118290 for Robert Litman, M.D. on February 20, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118290
- Company Name: Robert Litman, M.D.
- Inspection Date: 2020-02-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1264213 - 2025-03-04](https://www.globalkeysolutions.net/records/fda_inspections/robert-litman-md/e474dd45-081b-497d-b646-b63427c57ab3)
- [FDA Inspection 1264213 - 2025-03-04](https://www.globalkeysolutions.net/records/fda_inspections/robert-litman-md/dcc54746-a6ad-47cc-b15b-ea45e3eec152)
- [FDA Inspection 819517 - 2013-01-29](https://www.globalkeysolutions.net/records/fda_inspections/robert-litman-md/ec000bde-068b-4a80-891a-163a4ad6e0d9)

Company: https://www.globalkeysolutions.net/companies/robert-litman-md/f4a2d872-0435-4df3-9949-2fda169fc6c3

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c